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1. Introduction 
Subject of this article is to show how research can be build up and what fields are to 
consider. If you want to perform modern research you have to look at different aspects of 
the same problem. Therefore we established three research groups to illuminate the problem 
of ischemia and reperfusion injury after aortic clamping. The aim of this three study groups 
is to find answers to questions in the field of pre- and perioperative conditioning to improve 
the outcome or even avoid negative effects of an ischemia reperfusion injury upcoming 
every day in the clinical situation of a vascular surgeon.  
There is a high prevalence of hypertonia and arteriosclerosis in the industrial countries in 
our days. Therefore we have to expect an increase in the incidence of aortic aneurysms 
and the need for surgical intervention. Other reasons for aortic damage are injuries after 
trauma and dissections of the vascular wall. Thoracic aneurysms appear in nearly 25 % of 
the cases whereas abdominal aneurysms take place in round about 75 %. In most of the 
cases the aneurysm has to be resected operatively. During this procedure the blood flow is 
stopped by two clamps putted up- and downward of the aneurysm. The aneurysmatic 
vessel is replaced by prosthesis and blood flow is restored (Orend 1995). This means that 
all organs, supplied by this part of the aorta, are suffering from ischemia during the 
surgical procedure. 
Nearly 30 % of all patients, undergoing surgical replacement of the thoracic-abdominal part 
of the aorta, are suffering afterwards from severe postoperative problems. These problems 
are caused by the inevitable ischemia of the lower body half during the clamping and the 
following reperfusion injury, taking place with the declamping of the aortic vessel. This is 
the reason why the replacement of an aortic aneurysm is a classical clinical example of an 
ischemia and reperfusion sequence. The most frequently upcoming complications after 
elective, open surgical repair of an aortic aneurysm are cardiovascular and respiratory 
insufficiency. Intraoperatively patients are endangered mostly by the huge change in 
hemodynamic situation, because clamping of the aorta causes a fulminant increase in blood 
pressure. Without pharmacological intervention the ejection fraction of the heart would 
decrease by 40 %. An ongoing overload of the heart would end in dilatation of the left 
ventricle with hypoperfusion  of the inner heart muscle, insufficiency of the mitral valve and 
lung edema resulting in cardiovascular arrest (Walther 2000). Blankensteijn et al state in a 
meta-analysis of 72 studies 4.9 to 13.6 % as cardial and 3.8 to 13.5 % as pulmonal 
complications (Blankensteijn 1998). 
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Paraplegia as a consequence of spinal ischemia is the most important complication after 
reconstruction of the thoracic aorta. The incidence of paraplegia depends on the 
aneurysmatic dimension and comorbidities and  ranges therefore from 0.5 %, in case of a 
small repair e.g. the aortic arch, to 40 % in case of a ruptured thoracic aortic aneurysm 
(Svensson 1993, Money 1994, Zvara 2002). Several potential reasons for postoperative 
paraplegia were experimentally evaluated. Main subjects were amongst others ischemia and 
the resulting hypoxia plus an increase of the liquor pressure during the clamping period 
and the reperfusion injury after declamping (Crawford 1990, Bergner 1992, Zvara 2002). 
Ischemia and reperfusion cause an increase of free radicals that consume the existing buffer 
enzymes (Gelman 1995, Willett 2001). During hypoxia mitochondrial phosphorylation slows 
down with a consecutive loss of ATP that causes inhibition of the membrane pumps that are 
responsible for cell homeostasis. Finally dysbalance of the Na+/K+-milieu appears 
accompanied by hyperkalemia, acidosis and cell edema. At the end cells undergo 
programmed death, called apoptosis (Abe 1995). An additional aggravating factor is that the 
anterior motor neurons and the spinal cord have a high metabolic rate in combination with 
low hypoxic tolerance (Sakurai 1998), that make the neurons extremely sensitive to 
fluctuations in oxygen supply. Another important thing is the time factor, because clamping 
shorter than 30 minutes shows only little impact on the neurological tissue while longer 
ischemia periods coincide with a high risk for neurological damage like e.g. paraplegia 
(Hatori 2000, Wahlberg 2002, Roques 2003). Adequate blood supply for the spinal tissue can 
be measured electro physiologically by using somatosensoric (SEP) or motor evoked 
potentials (MEP). SEP´s show mainly the signal transduction of the dorsal part of the spinal 
cord while the MEP´s allow the monitoring of the neurons of the anterior horn and of the 
tractus corticospinalis. Experiments comparing these two methods showed that SEP´s react 
with a delay on spinal cord ischemia and have a high wrong positive rate. In contrast 18 out 
of 38 patients that underwent thoracic-abdominal reconstruction of the aorta showed 
pathological MEP-results. This changing’s in MEP measurement were attenuated by 
protective procedures e.g. reinsertion of segmental arteries. A loss of more than 75 % of the 
baseline MEP amplitude was taken as a sign for an ischemic spinal cord dysfunction. 
Paraplegia rate in this study, using MEP monitoring, was 0 % (de Haan 1999, Meylaerts 1999, 
2000).  
The risk for renal complications is about 15 to 20 % and depends on location of aneurysm, 
mainly of the lower thoracoabdominal or infrarenal aorta (Back 2005) and on potentially 
existing preoperative damages of the renal tissue of the patients. Creatinine levels over 230 
mmol/L and – or renal ischemia time over 60 minutes increase the risk of postoperative 
necessary dialysis, that occurs in 5 to 10 % of the cases (Kazautchian 1994). In patient with 
acute kidney failure that results in postoperative dialysis prognosis worsen dramatically 
with an increase of mortality up to 75 %. The higher the preoperative creatinine level the 
poorer the postoperative outcome of the patients (Svensson 1993). These facts show the need 
for new strategies to attenuate the harmful impact of ischemia and reperfusion on the spinal 
cord and the renal tissue. Before patients can benefit from new e.g. drugs and therapies that 
avoid tissue damage, experiments must be done, that ensure safety to humans. Therefore a 
valid experimental model to investigate new strategies in the field of ischemia and 
reperfusion is warranted. The next chapters show how our group is working on different 
aspects of the same problem, namely ischemia and reperfusion, to show up new strategies 
and hopefully give answers to questions of clinical problems in a vascular department.  
www.intechopen.com
 
How to Find New Ways 
 
221 
2. Large animal model 
For the realisation of a valid large animal model pigs are the appropriate species. 
Anatomically (position and configuration of the thoracic and abdominal organs, spinal cord 
and blood supply) metabolically as well as physio- and pathophysiologically pigs show the 
biggest homology with humans (Dodds 1982). We used pigs of both gender with a body 
weight of 40 to 50 kg in average and about 3 to 4 month of age. Furthermore other animal 
models were described before by other experimental groups (de Haan 1999, Hellberg 2000, 
Meylaerts 1999, 2000). Therefore we adapted the experimental setup to fit our special needs 
to examine ischemia and reperfusion in a standardised model (Schelzig 2003, Kick 2007). 
Another advantage of a large animal model is the easy surgical preparation, the possibility 
for neurological examinations and the acquisition of enough blood samples for further 
analytics. Via femoral cut down, catheter sheaths were introduced into the Aa. femorales 
sinistra and dextra for distal blood pressure recording and placement of inflatable balloon 
catheters. One catheter was placed directly above the porcine aortic bifurcation, the other 
one directly downstream of the A. subclavia sinistra as shown in Figure 1.  
 
Fig. 1. Position of the two inflatable balloon catheters. 
This approach was chosen in order to prevent any perfusion of the spinal cord via collateral 
flow distal to the proximal balloon, which could result from variable origin of the A. 
radicularis magna anterior. The intra-aortic balloon occlusion was used in order to avoid the 
mechanical injury, related to a clamp placement and release per se. A mini-laparotomy was 
performed to place a catheter into the bladder for save and controlled urine sampling. To 
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examine the neurological function of the spinal cord we established motor evoked potentials 
(MEP) that were already described above. Three electrodes were placed in the pig’s 
calvarium and one in the soft palate for electric stimulation of the motor cortex. Answers of 
the peripheral nerves were assessed in the lower limbs. After this model was well 
established over several years we tested different substances to see if there is any benefit 
compared to control groups. The next chapters give a short overview of some of the studies 
performed with this animal model. 
2.1 Erythropoietin (EPO) 
One of the first drugs we tested was erythropoietin (EPO). The reasons for choosing a 
substance that is known for so many years were the experimental results of other groups 
that discovered new aspects of EPO. Experiments dealing with apoptosis and neurological 
disability after ischemic impact on the spinal cord showed that EPO had not only some 
positive effects but seemed to attenuate the damage to the motor neurons at a  notable range 
(Celik 2002). There were also reports of improved renal tissue function after ischemia and 
reperfusion in animal models (Ates 2005, Forman 2007). Interestingly EPO was already in 
focus of human studies dealing with stroke and also reporting beneficial effects in the 
patients outcome, even though this results were only preliminary (Ehrenreich 2002). After 
we were sure that EPO would be an interesting candidate to take a closer look at, we had the 
problem of which doses to take, because most of the experiments in literature used high 
EPO doses. Only some experimental groups examined doses comparable to those used in 
hospital dealing with anemia (Silver 2006) also showing positive effects on spinal cord and 
kidney damage after trauma and ischemia and reperfusion (Kaptanoglu 2004, Abdelrahman 
2004).  Therefore we started our large animal experiments dealing with “low dose” EPO and 
its effects on spinal cord and kidney function after an ischemia and reperfusion sequence. 
14 anesthetized, ventilated and instrumented pigs twice received EPO (n=8; 300IU/kg both 
over 30 minutes before as well as over 4 hours during reperfusion) or vehicle (n=6). During 
the early reperfusion period i.v. noradrenaline was titrated continuously as required to 
maintain MAP > 80 % of the baseline level. Kidney function was assessed by PAH- and 
creatinine-clearance, spinal cord function by motor evoked potentials and lower extremity 
reflexes, respectively. DNA damage in whole blood samples was evaluated with the alkaline 
version of the comet assay. Oxidative stress was determined by isoprostane, catalase and 
superoxiddismutase in blood and renal tissue. After 8 hours of reperfusion post mortem 
tissue samples were taken for histological evaluation. Kidney and spinal specimen were 
analysed for apoptosis (TUNEL-assay). Spinal cord damage was quantified using the Nissl 
staining. Results show that conditions were stable throughout the whole experiments, 
meaning that as well hemodynamics as parameters of gas exchange were comparable 
between both groups without significant differences. This is a strongly recommended 
requirement to gain results that allow comparison of the experimental groups. Interestingly 
the amount of given noradrenaline, needed to keep blood pressure in the targeted range, 
was significantly lower in the EPO treated group. The fact of stable hemodynamics in 
combination with lower need for catecholamine may indicate an improved peripheral 
vascular resistance. It is also possible that vasoconstrictor vessel response is improved by 
EPO. Because of the shortness noradrenaline must be given, it is very likely that with EPO 
treated animals also have an improved cardiac function. These findings fit well with 
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findings in other experiments demonstrating positive effects of EPO on the heart of rats after 
myocardial infarction (Moon 2005). Although there were no clinical differences related to 
the spinal cord function, assessed by lower limbs reflexes and MEP-Amplitudes, we saw a 
significant higher number of intact neurons in the thoracic histological Nissl-stainings. This 
benefit unfortunately was lost in the lumbar histological staining, while HE-staining in both, 
the thoracic and the lumbar slices, showed cytoplasmatic swelling and vacuolisation as an 
indicator for spinal cord injury. 
 
Fig. 2. Nissl-staining of a spinal cord slice showing swollen neurons as a sign of hypoxic 
injury. 
Finally TUNEL-staining of microglia and astrocytes also imposed with less damage in the 
thoracic slices, but not at the lumbar level. These results show a positive effect of EPO on the 
neurological tissue, but this does not mean necessarily also an intact clinical outcome. One 
forth of the neurons was damaged by hypoxia, what might be too less for a proper function. 
The results of the kidney function showed an improvement as well of the creatinine 
clearance as of the fractional Na-excretion. Important in this context is that renal 
hemodynamics, namely renal blood flow, were comparable between the two groups 
meaning that differences between the groups are no artefacts caused by different 
postischemic perfusion. Urine production however was comparable between the groups. 
Interestingly these renal differences had no equivalent in the histological HE- or the 
TUNEL-staining. At least even systemic parameters of oxidative stress and antioxidant 
enzyme activity showed no intergroup differences. We can only have a guess why we have 
clinical relevant effects of EPO on the glomerular and tubular kidney function but see no 
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histological or oxidative stress parameters. One point of view might be that 45 minutes of 
ischemia is a relatively low challenge on renal tissue so that temporarily improved global 
renal function must not result in histological changing’s demonstrating a severe damage to 
the kidney tissue. This aspect is underlined by the gentle increase in plasma creatinine that 
indicates a possible recovering of the kidneys without any therapeutic intervention. The 
other point is that a reperfusion period of 8 hours might be too short to see already 
histological damages in renal tissue when the ischemic stress was not very excessive. In 
conclusion we can say that EPO has beneficial effects on cardiac and vascular 
hemodynamics, it improves the surviving of neuronal tissue and it protects kidney from 
acute failure. The lesson we learned out of that, was, that we can not examine two 
different organs in one single experimental setup and therefore have to split experiments 
in future. On the one hand we will have the spinal cord group with shorter clamping 
period and on the other hand we will have the kidney branch with prolonged ischemia 
time (Simon 2008). 
2.2 H2S – proof of principle 
The second substance we focused on was the hydrogen sulfide (H2S), because there was a 
remarkable study in mice. In this experiment mice were exposed to an atmosphere with 80 
ppm H2S. Just by inhaling this gas atmosphere the animals fell in a “suspended animation-
like” metabolic status. This is characterised by reduced metabolism, hypothermia and 
reduced O2 demand. The interesting fact in this context was that exposition of the animals to 
normal atmosphere reversed all of the mentioned effects without resulting in neurological 
damage (Blackstone 2005). This is of specific interest while H2S was known as a toxic agent 
harmful to humans (Couch 2005, Truong 2006), but recently came to mind as a third gaseous 
mediator (Lowicka 2007). One explanation might be the cytochrome oxidase c inhibition and 
the resulting reduction of the mitochondrial respiratory chain work und thus protecting 
animals from getting harmed by lethal hypoxia (Khan 1990, Blackstone 2007). To get further 
information if a “suspended animation-like” status is clinically relevant we wanted to know 
if we can translate the mice experiments in our large animal model, because small animals 
drop their body temperature much easier than large animals or humans and this might be a 
very important difference. Two major hypotheses were investigated: Is it possible to induce 
a reduced metabolic status in our large animal model as described in mice by using H2S as 
an i.v. formulation, to avoid airway irritation of the sulfide gas. Second aim was to see if H2S 
has any effect on the cardiovascular system, because sulfide was reported to be protective to 
the post-ischemic heart function (Johansen 2006, Zhu 2007). After an initial bolus H2S was 
given continuously with doses of 2 mg/kg per h until the end of the experiment. Control 
group received instead of sulfide only vehicle. After 2 hours of drug infusion the aortic 
blood flow was arrested for 30 minutes by using balloon catheters as described above. This 
occlusion time was chosen to investigate hemodynamics and metabolic changings and 
cardiovascular reaction without the adulteration of a huge inflammation reaction caused by 
the ischemia and reperfusion sequence. Reperfusion monitoring was 8 hours long with the 
followed killing of the animals in deep anaesthesia. The results showed that sulfide caused 
indeed a fall of heart rate and of cardiac output as well and came hand in hand with a 
reduction of noradrenaline in time and total amount, but did not affect stroke volume. 
Important in this context is that neither mean arterial nor venous pressure differed between 
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the groups so that it is plausible that changing’s of cardiac output was caused solely by the 
fall of heart frequency and that the vasoconstrictor response to the noradrenaline infusion 
was improved although in literature H2S is described as an endogenous vasodilator (Bhatia 
2005, Fiorucci 2006). Core temperature decreased in the H2S stronger than in the control 
group and reached significance at the end of experiment. This loss of temperature came 
together with a lowered O2 uptake and CO2 production after 2 hours of reperfusion and 
remained until the end of experiment after 8 hours of reperfusion. 
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§ depicts p < 0.05 control vs. sulfide. 
Fig. 3. O2 uptake and CO2 production in the vehicle (light whiskers) and sulfide-treated 
(dark whiskers) animals. All data are median (quartiles, range), n = 8 in each group. 
This reduction of metabolism also caused consequently less need for anaerobic generation of 
ATP and therefore also less glucose turnover. As we planed there was no intergroup 
difference between the parameters of inflammation and oxidative stress, namely isoprostan 
levels, nitrate plus nitrite and TNF-ǂ. The reason for that mild inflammation and oxidative 
stress response is the relatively short ischemia, giving us the opportunity to study just the 
effects of sulfide per se. What we found unfortunately was a significant lower pO2 level in 
the sulfide group at the end of the experiments while pCO2 and acid-base status didn’t 
change. The reason for this loss of lung function was seen when the lung was taken out at 
the end of the last experiment. There was a diffuse lung haemorrhage suggesting that 
longterm infusion of sulphide in high doses can cause pulmonary toxicity. In conclusion we 
demonstrated in our large animal model that i.v. H2S reduces significantly metabolism and 
energy expenditure. It also reduced noradrenaline requirements during the early 
reperfusion period and might have positive effects on the cardiovascular system, but may 
cause pulmonary irritations up to acute lung failure. (Simon 2008) 
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2.3 H2S – 90 minutes of kidney ischemia 
With the knowledge of the previous H2S experiment, we wanted to develop further the idea 
of a “suspended animation-like” status and its benefits to kidneys suffering from an 
ischemia and reperfusion sequence, especially since sulfide showed beneficially effects in 
renal I/R injury (Tripatara 2009, Xu 2009). These effects were also seen in porcine models 
dealing with myocardial I/R injury and in isolated kidney preparations, mainly by the 
reduction of inflammatory response and oxidative stress (Sodha 2009, Hosgood 2010). 
Therefore we were interested if H2S could reduce the renal tissue damage in our large 
animal model, described above with a special interest in the global kidney function, the 
animal metabolism, body temperature and parameters of inflammation and oxidative stress. 
After the initial bolus was given, the infusion rate was again 2 mg/kg per h for the first two 
hours but then was halved to 1 mg/kg per h. During the 90 minutes of aortic clamping the 
infusion rate was only 0.5 mg/kg per h, to avoid toxic accumulation. For the rest of the 
procedure please see above. As already described, it is important to keep animals in 
comparable conditions to avoid artefacts. Hemodynamics, gas exchange, acid-base and 
electrolyte parameters did not differ between the two groups prior to aortic occlusion, 
except for a little difference in blood pressure level in the sulfide group that was a little bit 
lower compared to the control group. Again H2S caused a fall of body temperature and 
heart rate and reduced again the need for noradrenaline. Postischemic acidosis and 
hyperkalemia were attenuated by sulfide. While there were comparable renal perfusion 
conditions the kidney function differed in favour for the H2S animals. Plasma creatinine and 
creatinine clearance showed an improved function of the renal tissue while there was no 
difference in the fractional Na+-excretion. At the first glance it looks as if sulfide would not 
benefit renal tubular cells, but there is evidence, that it influences Na+-exchange directly, 
because H2S caused a 5 fold increase in fractional excretion while there was only a rise of 50 
to 80 % in glomerular filtration (Xia 2009). Control animals showed “renal failure” and a 
“stage 2 kidney injury” in the RIFLE and AKIN classification (Cruz 2009). Sulfide caused 
only a mild increase of IL-6, IL-1β and nitrite + nitrate what came hand in hand with lower 
oxidative DNA base damage, measured with the comet assay, and iNOS expression, 
underlining the anti-inflammatory and NO-release attenuating effect of H2S (Sodha 2009, 
Tripatara 2008, Hosgood 2010). The drop in body temperature is unlikely to be the reason as 
there is a deeper hypothermia recommended to affect inflammation in a relevant manner 
(Chen 2005). Heme oxygenase-1 (HO-1) and cleaved caspase-3 were similar in both groups 
while sulfide reduced expression of the anti-apoptotic protein Bcl-xL and increased nuclear 
transcription factor NF-κB. Interestingly NF-κB not only has inflammatory properties, but 
also quite the opposite, especially in renal tissue and may contribute to the anti-
inflammatory effect seen in our experiment (Lawrence 2005, Panzer 2009). Contrary to the 
missing anti-inflammatory effect of the lower body temperature, there might be a beneficial 
effect of mild hypothermia on the protective properties of NF-κB during I/R injury (Kuboki 
2007). The most important change in histopathology was the reduction of the “glomerular 
tubularization”, while the rest of the histological staining only showed mild glomerular 
swelling, flattening of tubulus epithelium and intra-tubular deposits. Even TUNEL-staining 
showed comparable results between the two groups. This seems to be in contrast with other 
authors, evaluating more severe histological damages to the renal tissue after I/R injury 
(Forman 2007, Sanchez-Conde 2008). 
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§ p<0.05 versus control group. 
Fig. 4. Blood creatinine levels and creatinine clearance in the control (light whiskers) and 
sulfide-treated animals (dark whiskers). All data are median (quartiles, range), control n=10, 
sulfide n=9,  
The crucial point seems to be again the relatively short reperfusion period, because other 
experiments show comparable results after short post ischemic monitoring (Behrends 2000). 
This time factor seems also to be involved in the missing differences of HO-1 with a 
potential latency up to 24 hours (Calvert 2009). In conclusion we demonstrated in a clinically 
relevant porcine I/R injury model, that i.v. sulfide administration improved kidney function 
coming together with an anti-inflammatory effect and reduced DNA damage and NO 
release. The higher NF-κB activation was probably due to the drop in temperature (Simon 
2011). 
3. Small animal model 
We established a small animal model to give answers to questions of the longer outcome of 
potential therapies, because in our pig model, with sacrifice of the animal at the end of the 
experiment the neurological outcome cannot be determined. The killing of the pigs at the 
end of the experiments is necessary, because of the positioning of the proximal balloon 
catheter, as described above, and the resultant hemodynamic imbalance as well as the 
ischemia of the abdominal organs. Much more compelling would be to monitor for several 
days the postoperative neurological outcome of awake animals after such an I/R injury. In 
New Zealand White Rabbit’s spinal ischemia can be induced by cross-clamping of the 
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infrarenal aorta due to strictly segmental blood supply of the spinal cord and can be 
therefore taken as a model for thoracic aortic clamping in pigs and humans respectively 
(Zivin 1980). In this way it is possible to keep the surgical impact relatively small, to avoid 
ischemia of the visceral organs and to keep hemodynamics stable without pharmacological 
intervention. Inspired by the experiments and experiences of our large animal model and 
the EPO drug (Simon 2008) we were interested now to examine the effects of a carbamylated 
derivative of EPO, the so called cEPO. Compared to EPO, whose neuroprotective abilities 
have been discussed above, the cEPO is lacking of the erythropoietic component (Doggrell 
2004), but with all of the tissue protective characteristics of the native EPO. Cytoprotective 
effects are transmitted by a two-piece receptor, that has on the one hand an EPO receptor 
and on the other hand a special ǃ-subunit. Experiments with mice lacking this subunit, 
showed no tissue protective effects (Brines 2004). This is of special interest, because 
erythropoiesis might be undesired in ill patients with hypertonia. 20 New Zealand White 
Rabbits were randomly distributed to either the control or the cEPO therapy group and were 
anesthetized by a mixture of ketamine (50mg/kg body weight) and xylazine (5mg/kg). Blood 
pressure, heart rate, oxygen saturation and temperature were monitored intraoperatively.  In 
preliminary trials a clamping time of 15 min was defined as being optimal. After this clamping 
time all animals imposed initially with complete paraplegia and a recovering during the first 
24 hours with a following incomplete re-paraplegia as a sign of the reperfusion injury. 
Animals received vehicle or cEPO over a period of 30 minutes prior to ischemia and with the 
same doses during the first 30 minutes of reperfusion. Neurological tests took place at 6h, 24h, 
36h, 48h, 60h, 72h, 84h and 96h of reperfusion using a modified form of the Tarlov-score, 
describing the motoric-neurological function of the lower limbs, with a point score. After 96 h 
the spinal cord was taken out for histopathological examination.  
 
Fig. 5. Spinal cord explanted “in toto” after 96 hours of reperfusion (Th3-L5).  
In the results the control and the therapy animals showed postoperatively complete 
paraplegia as supposed (Tarlov = 0). After 6 h of reperfusion control animals recovered a 
little in the neurological examination (Tarlov = 4.25). This improvement remained until 36 h 
of reperfusion with a subsequent deterioration until 96 h at the end of the experiment 
(Tarlov = 3.625). Aetiopathology in the cEPO group was similar to the control group with a 
primary recovering up to 24 h after surgery (Tarlov = 4.25) and a tableau until 36 h (Tarlov = 
4) and a subsequent worsening until 96 h (Tarlov = 3.5). There was unfortunately no 
significant difference between the two groups. Histopathological examination did not reveal 
any injury in thoracic sections of the spinal cord whereas damage in lumbal sections 
correlated significantly with neurological symptoms (p=0.007). The treatment group (cEPO) 
and the placebo group showed no differences in neurological or histopathological outcome. 
Again we learned a lot out of this animal model especially that the time factor varies 
between different animal models. Even literature can not answer questions to the correct 
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ischemia duration in a rabbit model, because some groups had good results after 15 minutes 
(Lee 2005) others needed 25 minutes (Jacobs 1992) or 30 minutes (Oz 2007) or even 40 
minutes (Lafci 2008). We have to state that in our small animal model with rabbits a 
clamping time of 15 minutes may be questioned, because, as described above, we saw a fast 
recovering from paraplegia meanwhile the first 24 hours with no animal imposing with a 
complete paraplegia to the end after 96 hours. 
 
Fig. 6. Slice of the necrotic lumbar spinal cord (L2) with cellular inflammation reaction.  
Our decision to work with a clamping time of 15 minutes is based on our aim to keep 
clamping time and surgery as short as possible to spare the animals. Looking now at the 
results we have to say that there is no difference between the groups and that we can not 
exclude the possibility that clamping time was too short. The neuronal damage was not 
big enough to see potential benefits of the treatment group, because the control group 
came out well, too. Therefore we can only speculate if the results are due to the short 
clamping time or just to the ineffectiveness of the cEPO drug. Statistically we found a 
huge range of variance in our results, what might be not unusual (Zivin 1980), but may 
disturb our database to see relevant intergroup differences. Therefore further 
investigations are warranted. In conclusion this is a highly reproducible model which 
allows clinical neurological assessment after aortic cross-clamping. Using this model 
promising pharmaceutics, influencing ischemia tolerance, can be tested clinically and 
histopathologically. In the initial experimental series with a cross-clamping time of 15 min 
no significant improvement of the clinical or histological damage could be achieved by 
administration of cEPO, what might be due to a too short clamping time (Simon 2010). 
4. Cell culture 
Cell culture is a possibility to illuminate processes on the level of genes and proteins as well 
as changings during hypoxia and reoxigenation. Additional substances and / or therapies 
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can be tested before realising cost and time intensive large animal models. Subjects of 
interest are tubular and neuronal cells as representative tissue samples of the organs 
examined in our animal models described above. To realise this aim we used permanent 
human (HEK293) and porcine (LLC-PK1 and PK15) renal cells. Evaluation of the system was 
performed by determination of the hypoxia inducing factor 1 alpha (HIF1ǂ) which plays an 
important role of the O2 regulation in every cell (Ivan 2001, Jaakkola 2001, Bardos 2004). We 
also determined expression of Proteinkinase beta 1 (AMPKǃ1), which is activated by an 
elevated AMP/ATP ratio due to cellular and environmental stress, such as heat shock, 
hypoxia and ischemia (Hardie 2004). In both, human (HEK293) und porcine (LLC-PK1) 
kidney cells we saw that cells are quite tolerant to short (1-2 h) and middle (4-8 h) hypoxic 
periods, but a distinct upregulation of protein expression occurs after 18 to 24  hours of 
cultivation under hypoxic conditions. After 24 h of hypoxia the cells where reoxygenised. 
For characterisation of the system examinations of the cell morphology, distribution of 
intact, apoptotic and necrotic cells as well as expression of multiple apoptotic relevant genes 
on protein level were done. Induction of hypoxia is performed by manipulation of the O2 
content of the cultivating medium, induced by a devolatilization of the cultivation medium 
and by using a standardised hypoxic chamber which is flushed with nitrogen. In this way 
we were able to combine different hypoxic timepoints with diverse reoxygenation 
durations. After putting the hypoxia medium on the cells they were cultivated in a 
hypoxic chamber. We compared normoxic cells with hypoxic ones. Expressions of the 
normoxic cells were taken as baseline and compared to hypoxic and reoxygenised cells, 
each with or without treatment. Target genes were caspase 3 and cleaved caspase 3 as a 
marker for apoptosis, HIF-1ǂ (Hypoxia induced factor) to evaluate hypoxia, Bcl-2 and 
Bcl2xL as antiapoptotic markers as well as Bax, as a proapoptotic marker of mitochondrial 
apoptosis. By using these methods it is possible to see differences in the gene expression 
in cells cultivated during hypoxic and normoxic conditions and how these things change 
under the treatment with potentially protective substances. After 24 hours of hypoxia we 
basically found expression of pro-apoptotic stimuli like Bax or rather severely deranged 
ratio of Bax and Bcl-2. We have Cytochrome c release, which can lead to activation of 
caspase 9 that processes caspase 3 and initiates to the formation of the apoptosome. And 
we have distinct release of other apoptotic factors, e.g. “Second-mitochondria-derived 
activator of caspase” in short Smac/Diablo, which counteracts the effect of inhibitors of 
apoptosis. These data are a second validation for our hypoxia model, because the intrinsic 
pathway of apoptosis begins when injury occurs within the cell, such as e.g. DNA 
damage, hypoxia and depravation of survival factors. Western blot was used to detect 
gene expression on protein level. Therefore proteins are isolated out of the target cells and 
then were separated by size using the “sodium dodecylsulfate polyacrylamide” gel 
electrophoresis (SDS-Page) and blotted on a nitrocellulose membrane. After treatment 
with a specific antibody, amplifying the primary antibody by a second one, it can be 
detected if a protein is expressed or not, compared to a standard protein in defined 
volume. To identify morphologic changings in mitochondria, cells were stained with the 
MitoTrackerRed, a mitochondria specific fluorescent dye. MitoTrackerRed Dyes stain 
mitochondria in living cells and its accumulation in the cell depends on the membrane 
potential. This means that a loss of fluorescence is caused by a decreased mitochondrial 
activity. 
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Fig. 7. MitoTrackerRed-staining in normoxic cells (left) and in cells after 24 hours of hypoxia 
(right). 
We saw microscopic mitochondrial structures such as shape, localisation inside the cell and 
number of active mitochondria. Mitochondria seemed to be much more compact and after 
long terms of hypoxia, they partly seem to be more diffuse and also a loss of active 
mitochondria could be detected. Oxidative stress occurring during ischemia and reperfusion 
injury affects mitochondrial function and therefore respiratory chain. Thus, in addition, to 
follow changes in respiratory chain during hypoxic period and reoxygenation oxygraphical 
studies (Oxygraph, Oroboros; Austria) were performed. With that method by titration of 
inhibitors and substrates it is possible to follow changes in several complexes of the 
respiratory chain. Therefore it is possible to distinguish activities and dysfunction of the 
respiratory chain in particular. A classic titration protocol starts with state 1 respiration, 
which means endogenous substrates, no adenylates, with inorganic phosphates in the 
mitochondrial respiration medium. As expected we monitored a lowered state 1 respiration 
in hypoxic cells and a recovery after 24 h of reoxygenation. Another interesting point is the 
maximum respiration capacity of the cells and again, we found distinct lowered values in 
hypoxic cells and a slowly recovery after reoxygenation. We always compared normoxic 
cells with hypoxic ones. After these experiments we looked at the effects of EPO and cEPO 
on hypoxic cells. We tested two approaches. At first we admitted substances before the 24 
hour hypoxic period and as second attempt during this period. What we saw is a 
downregulation of HIF-1ǂ expression to nearly normoxic control level under high EPO / 
cEPO doses (100 – 1000 IU/ 5 ml medium) given during hypoxia in human and pig kidney 
cells. Concerning activities on mitochondrial bases, we analysed Bcl-2 as an anti-apoptotic 
mitochondrial marker and its antagonist Bax. We found a loss of Bcl-2 after 24 h hypoxic 
stress and a rise of Bax. So the Bcl-2/Bax ratio is severely deranged, which contributes to 
cellular apoptosis. But we also found these expressions re-adjusted with the help of EPO or 
cEPO. In addition we examined cellular proliferation, based on a luminescent assay. The 
assay, determining the number of viable cells in culture based on quantification of the ATP, 
is an indicator of metabolically active cells. The amount of ATP is directly proportional to 
the number of cells present in culture. What we saw, was no influence of cEPO in the control 
www.intechopen.com
 
Vascular Surgery 
 
232 
cells. As expected there was a reduced proliferation rate after 24 h of hypoxia, but also 
improved proliferation with cEPO treated cells. After 24h of hypoxia and 24h of 
reoxygenation nearly control level was reached again. In the long run we will work with 
primary renal and spinal cord cells, because I/R injury not only affect kidney but also spinal 
cord. Therefore we are interested in working with neuronal cells. Yet we did first steps with 
hippocampal primary neurons extracted from rat embryos, but in the near future it is 
planned not only to deprive oxygen but also to test a combination of oxygen and glucose 
deprivation. Also of particular importance is the examination of DNA damage during 
hypoxia, reoxygenation and drug treatment. Further projects will also deal with the effects 
of hypothermia on the cell system. The cell culture project is still developing and we learn a 
lot day by day so that these experiments, described above, are only the very beginning of 
our studies with cell culture and serves until now more or less only as a standardisation 
model with further projects and publications coming in the near future. 
5. Conclusion 
Aim of our studies is to examine systematically the phenomenon of the ischemia and 
reperfusion injury in common and in the aortic surgery in special. These experiments are 
important to develop pre- and perioperative concepts to improve clinical outcome of 
patients in the future. The models described above started their evolution 10 years ago and 
developed and expanded over the years. It is possible to study not only acute but also 
elective surgery situations and therefore might give answers to problems in the everyday 
life of a vascular surgeon to reduce morbidity and mortality in the aortic surgery. 
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